Kenvue Inc. (KVUE)
Bid | 22.71 |
Market Cap | 43.54B |
Revenue (ttm) | 15.46B |
Net Income (ttm) | 1.03B |
EPS (ttm) | 0.54 |
PE Ratio (ttm) | 42.03 |
Forward PE | 17.7 |
Analyst | Hold |
Ask | 23 |
Volume | 11,999,255 |
Avg. Volume (20D) | 16,453,959.3 |
Open | 22.37 |
Previous Close | 22.09 |
Day's Range | 22.19 - 22.89 |
52-Week Range | 17.67 - 24.46 |
Beta | 1.21 |
About KVUE
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the ...
Analyst Forecast
According to 13 analyst ratings, the average rating for KVUE stock is "Hold." The 12-month stock price forecast is $24, which is an increase of 5.75% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

1 month ago · seekingalpha.com
Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty'Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for accumulation during market volatility. Despite being off their highs, both JNJ and...